Katsoulis Orestis, Pitts Oliver R, Singanayagam Aran
Centre for Bacterial Resistance Biology, Department of Infectious Disease, Imperial College London, London SW7 2DD, UK.
National Heart and Lung Institute, Imperial College London, London SW7 2DD, UK.
Oxf Open Immunol. 2024 Aug 22;5(1):iqae009. doi: 10.1093/oxfimm/iqae009. eCollection 2024.
The existence of commensal fungi that reside within the respiratory tract, termed the airway mycobiome, has only recently been discovered. Studies are beginning to characterize the spectrum of fungi that inhabit the human upper and lower respiratory tract but heterogeneous sampling and analysis techniques have limited the generalizability of findings to date. In this review, we discuss existing studies that have examined the respiratory mycobiota in healthy individuals and in those with inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease and cystic fibrosis. Associations between specific fungi and features of disease pathogenesis are emerging but the precise functional consequences imparted by mycobiota upon the immune system remain poorly understood. It is imperative that further research is conducted in this important area as a more detailed understanding could facilitate the development of novel approaches to manipulating the mycobiome for therapeutic benefit.
呼吸道中存在的共生真菌,即气道真菌群,直到最近才被发现。研究开始对栖息于人类上、下呼吸道的真菌谱进行特征描述,但采样和分析技术的异质性限制了迄今为止研究结果的普遍性。在这篇综述中,我们讨论了现有研究,这些研究调查了健康个体以及患有炎症性肺部疾病(如哮喘、慢性阻塞性肺疾病和囊性纤维化)的个体的呼吸道真菌群。特定真菌与疾病发病机制特征之间的关联正在显现,但真菌群对免疫系统产生的精确功能后果仍知之甚少。在这一重要领域开展进一步研究势在必行,因为更详细的了解可能有助于开发操纵真菌群以获得治疗益处的新方法。